Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Medicinal Chemistry
|
November 5, 2015
Small Molecule CXCR3 Antagonists
Stephen P Andrews, Rhona J Cox
Accounts of Chemical Research
|
February 19, 2003
Paraherquamides, brevianamides, and asperparalines: laboratory synthesis and biosynthesis. An interim report
Robert M Williams, Rhona J Cox
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 23, 2019
Plasma Protein Binding as an Optimizable Parameter for Acidic Drugs
Philip Gardiner, Rhona J Cox, Ken Grime
Future Medicinal Chemistry
|
April 21, 2021
The powerful symbiosis between synthetic and medicinal chemistry
Stefan Schiesser, Rhona J Cox, Werngard Czechtizky
Journal of the American Chemical Society
|
October 2, 2003
Asymmetric, stereocontrolled total synthesis of paraherquamide A
Robert M Williams, Jianhua Cao, Hidekazu Tsujishima, et al.
Journal of Medicinal Chemistry
|
October 28, 2020
<i>N</i>-Trifluoromethyl Amines and Azoles: An Underexplored Functional Group in the Medicinal Chemist's Toolbox
Stefan Schiesser, Hanna Chepliaka, Johanna Kollback, et al.
Progress in Medicinal Chemistry
|
June 26, 2022
Advances in the design of new types of inhaled medicines
Werngard Czechtizky, Wu Su, Lena Ripa, et al.
European Journal of Medicinal Chemistry
|
November 6, 2021
Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors
Stefan Schiesser, Peter Hajek, Huw E Pople, et al.
Organic Letters
|
September 4, 2007
The first synthesis of the ABC-ring system of 'upenamide
Jan Peter Schmidt, Sandra Beltrán-Rodil, Rhona J Cox, et al.
Plos One
|
September 2, 2020
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
Celine Dumont, Ulf Sivars, Theresa Andreasson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Medicinal Chemistry
|
November 5, 2015
Small Molecule CXCR3 Antagonists
Stephen P Andrews, Rhona J Cox
Accounts of Chemical Research
|
February 19, 2003
Paraherquamides, brevianamides, and asperparalines: laboratory synthesis and biosynthesis. An interim report
Robert M Williams, Rhona J Cox
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 23, 2019
Plasma Protein Binding as an Optimizable Parameter for Acidic Drugs
Philip Gardiner, Rhona J Cox, Ken Grime
Future Medicinal Chemistry
|
April 21, 2021
The powerful symbiosis between synthetic and medicinal chemistry
Stefan Schiesser, Rhona J Cox, Werngard Czechtizky
Journal of the American Chemical Society
|
October 2, 2003
Asymmetric, stereocontrolled total synthesis of paraherquamide A
Robert M Williams, Jianhua Cao, Hidekazu Tsujishima, et al.
Journal of Medicinal Chemistry
|
October 28, 2020
<i>N</i>-Trifluoromethyl Amines and Azoles: An Underexplored Functional Group in the Medicinal Chemist's Toolbox
Stefan Schiesser, Hanna Chepliaka, Johanna Kollback, et al.
Progress in Medicinal Chemistry
|
June 26, 2022
Advances in the design of new types of inhaled medicines
Werngard Czechtizky, Wu Su, Lena Ripa, et al.
European Journal of Medicinal Chemistry
|
November 6, 2021
Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors
Stefan Schiesser, Peter Hajek, Huw E Pople, et al.
Organic Letters
|
September 4, 2007
The first synthesis of the ABC-ring system of 'upenamide
Jan Peter Schmidt, Sandra Beltrán-Rodil, Rhona J Cox, et al.
Plos One
|
September 2, 2020
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
Celine Dumont, Ulf Sivars, Theresa Andreasson, et al.
Page
of 2